About: Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1998 (uk) articolo scientifico (pubblicato il 1998) (it) im Januar 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1998 (ast) scientific article published on 01 January 1998 (en) artikull shkencor i botuar më 01 janar 1998 (sq)
publication date	wds:Q74082930-F475F263-AB5E-4A65-8BFF-E059B1355A30
publication date	1998-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74082930-AEBAF6D9-5253-475D-81FD-099D9A83EFE2
language of work or name	English
author name string	wds:Q74082930-0C44CFBE-4BD0-4396-AFB8-DD4C1A809936 wds:Q74082930-0C6C4B7A-A326-4C24-888C-78B2954F9CE9 wds:Q74082930-2B04CC42-4E70-417D-BBE4-78474D51E231 wds:Q74082930-2D79F9C6-E9BF-4961-A923-1163066FC682 wds:Q74082930-4FFE8011-98CC-46DE-8DFD-884BD19E593F wds:Q74082930-8234CC4E-69EF-4659-B973-9160239F0AE2 wds:Q74082930-9135E79C-A351-498B-8453-21A5A434D99B wds:Q74082930-93A83114-28EB-472C-BD0F-28A3EF02189B wds:Q74082930-F766F375-4116-40DB-86C4-39BEC16C8E92
author name string	S J Forman P J Stiff R I Fisher M LeBlanc K G Blume S J Horning S Dahlberg A P Nademanee A R McCall
rdfs:label	Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial (en) Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial (nl) Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial (sq)
skos:prefLabel	Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial (en) Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial (nl) Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial (sq)
name	Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial (en) Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial (nl) Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial (sq)
title	wds:Q74082930-5A8D32AD-643B-4439-B563-AD5160806B2B
title	Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial (en)
page(s)	wds:Q74082930-333C1A74-F47E-4BC3-B1CB-44F6A39E73B2
page(s)	48-55
instance of	wds:Q74082930-1C0B8AFA-BC9B-46B7-8B26-EDB3B94851BC
instance of	scholarly article
PubMed ID	wds:Q74082930-5008F051-4CF7-4222-B138-098488CEA5F6
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9440722
PubMed ID	9440722
published in	wds:Q74082930-08C6D3F4-1078-4A04-8607-145473E08A83
published in	Journal of Clinical Oncology
issue	wds:Q74082930-EE1A4F82-1FC8-4D0E-9126-4B719CA27E03
volume	wds:Q74082930-67D6245D-656C-42E0-91F0-C7A690BD743C
issue	1
volume	16
DOI	wds:Q74082930-452448EE-4061-477D-9272-E86BE0A2429B
DOI	http://dx.doi.org/10.1200/JCO.1998.16.1.48
DOI	10.1200/JCO.1998.16.1.48
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74082930
is cites work of	High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients Influence of age and histology on outcome in adult non-Hodgkin lymphoma patients undergoing autologous hematopoietic cell transplantation (HCT): a report from the Center For International Blood & Marrow Transplant Research (CIBMTR). Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy. Ontario BMT Network, Canada. The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial Imaging of non-Hodgkin lymphomas: diagnosis and response-adapted strategies. A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older. High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma. Positron emission tomography with [18F]FDG for therapy response monitoring in lymphoma patients Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma. A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road? Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 ra Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy. Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma? Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era. Autologous stem cell transplantation for aggressive lymphomas. LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma Localized radiation increases morbidity and mortality after TBI-containing autologous stem cell transplantation in patients with lymphoma A novel preparative regimen for autologous transplant in non-Hodgkin's lymphoma: long-term experience with etoposide and thiotepa The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma. Carmustine infusion reactions are more common with rapid administration Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies Therapeutic results in patients with relapsed diffuse large B cell Non-Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation. BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin's lymphomas High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma. Cyclophosphamide, etoposide and carboplatine plus non-cryopreserved autologous peripheral blood stem cell transplantation rescue for patients with refractory or relapsed non-Hodgkin's lymphomas. Finding the Optimal Conditioning Regimen for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation: A Retrospective Comparison of BEAM and High-Dose ICE Study of conditioning regimens with or without high-dose radiotherapy before autologous stem cell transplantation for treating aggressive lymphoma
is cites work of	wds:Q32118783-3266C900-2DF1-4FB2-B45D-A1B7BCD0D61B wds:Q43918953-B5762391-373C-4692-A2F2-0D43090A8256

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software